Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine vs Milrinone for Renal Recovery in Cardiorenal Syndrome
NCT02644057Phase 2Withdrawn
- Sponsor
- Maimonides Medical Center
- Start
- Mar 2016
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dobutamine, milrinone in cardiorenal syndrome (CRS), heart failure (HF), sponsored by Maimonides Medical Center. Planned start Mar 2016; status: withdrawn.
02
Drugs
dobutaminemilrinone
03
Conditions
cardiorenal syndrome (CRS)heart failure (HF)
Beyond the preview
Go deeper on NCT02644057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02644057.